Sabina Bonell
About Sabina Bonell
Sabina Bonell is a Pharmacovigilance Medical Writer and Drug Safety Officer with extensive experience in the field. She has worked at TFS Trial Form Support since 2018 and has a background in research from the University of Barcelona and Universitat Autònoma de Barcelona.
Current Role at TFS HealthScience
Sabina Bonell serves as a Pharmacovigilance Medical Writer and Drug Safety Officer at TFS Trial Form Support. She has held this position since 2018, contributing to the company's efforts in ensuring drug safety and compliance. In her role, she is responsible for writing and reviewing medical documents related to pharmacovigilance, which involves monitoring the effects of pharmaceutical products after they have been released on the market.
Previous Experience at University of Barcelona
Prior to her current position, Sabina Bonell worked at the University of Barcelona for nine months in 2017. During this time, she focused on a project related to dermatoglyphics and prenatal alcohol exposure. This experience provided her with valuable insights into research methodologies and data analysis in the field of medical science.
Educational Background
Sabina Bonell studied at Universitat Autònoma de Barcelona from 2011 to 2016, completing her degree over a five-year period. Her education laid the foundation for her career in pharmacovigilance and medical writing. Additionally, she briefly attended a medical academy in Wroclaw in 2015, further enhancing her knowledge in the medical field.
Early Career at Jules
Before her career in the medical field, Sabina Bonell worked at Jules from 2010 to 2014. In this role, she provided customer service and sales advice in the clothing sector. This experience contributed to her skills in communication and client interaction, which are valuable in her current medical writing role.
Research Experience at Universitat Autònoma de Barcelona
Sabina Bonell also worked at Universitat Autònoma de Barcelona from 2015 to 2016 on a final degree project focused on microRNA in polycystic ovary syndrome. This nine-month project allowed her to engage in in-depth research and gain practical experience in the field of medical science.